Skip to content
Licensed Unlicensed Requires Authentication Published by De Gruyter October 12, 2019

Alarmed by misleading interference in free T3 and free T4 assays: a new case of anti-streptavidin antibodies

  • Yannick Wouters ORCID logo EMAIL logo , Julie Oosterbos , Nele Reynaert and Joris Penders
  1. Author contributions: All the authors have accepted responsibility for the entire content of this submitted manuscript and approved submission.

  2. Research funding: None declared.

  3. Employment or leadership: None declared.

  4. Honorarium: None declared.

  5. Competing interests: The funding organization(s) played no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the report; or in the decision to submit the report for publication.

References

1. Gurnell M, Halsall DJ, Chatterjee VK. What should be done when thyroid function tests do not make sense? Clin Endocrinol (Oxf) 2011;74:673–8.10.1111/j.1365-2265.2011.04023.xSearch in Google Scholar PubMed

2. Norden AG, Jackson RA, Norden LE, Griffin AJ, Barnes MA, Little JA. Misleading results from immunoassays of serum free thyroxine in the presence of rheumatoid factor. Clin Chem 1997;43:957–62.10.1093/clinchem/43.6.957Search in Google Scholar

3. Zaninotto M, Tognon C, Venturini R, Betterle C, Plebani M. Interference in thyroid hormones with Roche immunoassays: an unfinished story [Letter]. Clin Chem Lab Med 2014;52:e269–70.10.1515/cclm-2014-0454Search in Google Scholar PubMed

4. Van Der Watt G, Haarburger D, Berman P. Euthyroid patient with elevated serum free thyroxine. Clin Chem 2008;54:1239–41.10.1373/clinchem.2007.101428Search in Google Scholar PubMed

5. Bolstad N, Warren DJ, Nustad K. Heterophilic antibody interference in immunometric assays. Best Pract Res Clin Endocrinol Metab 2013;27:647–61.10.1016/j.beem.2013.05.011Search in Google Scholar PubMed

6. Piketty ML, Prie D, Sedel F, Bernard D, Hercend C, Chanson P, et al. High-dose biotin therapy leading to false biochemical endocrine profiles: validation of a simple method to overcome biotin interference. Clin Chem Lab Med 2017;55:817–25.10.1515/cclm-2016-1183Search in Google Scholar PubMed

7. Buijs MM, Gorgels JP, Endert E. Interference by antiruthenium antibodies in the Roche thyroid-stimulating hormone assay. Ann Clin Biochem 2011;48:276–81.10.1258/acb.2010.010160Search in Google Scholar PubMed

8. Favresse J, Lardinois B, Nassogne MC, Preumont V, Maiter D, Gruson D. Anti-streptavidin antibodies mimicking heterophilic antibodies in thyroid function tests. Clin Chem Lab Med 2018;56:e160–3.10.1515/cclm-2017-1027Search in Google Scholar PubMed

9. Bayart JL, Favresse J, Melnik E, Lardinois B, Fillée C, Maiter D, et al. Erroneous thyroid and steroid hormones profile due to anti-streptavidin antibodies. Clin Chem Lab Med 2019;57:e255–8.10.1515/cclm-2018-1355Search in Google Scholar PubMed

10. Ruth I, Mathieu E, Burniat A, Fage D, Cotton F, Wolff F. Interferences in free thyroxine concentration using the Roche analytical platform: improvement of the third generation? Clin Chem Lab Med 2020;58:e36–9.10.1515/cclm-2019-0525Search in Google Scholar PubMed

11. Favresse J, Burlacu MC, Maiter D, Gruson D. Interferences with thyroid function immunoassays: clinical implications and detection algorithm. Endocr Rev 2018;39:830–50.10.1210/er.2018-00119Search in Google Scholar PubMed

Received: 2019-08-11
Accepted: 2019-09-07
Published Online: 2019-10-12
Published in Print: 2020-02-25

©2020 Walter de Gruyter GmbH, Berlin/Boston

Downloaded on 18.4.2024 from https://www.degruyter.com/document/doi/10.1515/cclm-2019-0845/html
Scroll to top button